Thomas Civik - Oct 7, 2021 Form 3 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Thomas Civik
Stock symbol
PYXS
Transactions as of
Oct 7, 2021
Transactions value $
$0
Form type
3
Date filed
10/7/2021, 09:00 PM
Previous filing
Sep 9, 2021
Next filing
Nov 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PYXS Stock Option (Right to buy) Oct 7, 2021 Common Stock 15.7K $8.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in three, substantially-equal annual installments beginning on the first anniversary of the August 19, 2021 grant date, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney